Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease

25Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Baseline level of the cysteinyl leukotriene (CysLT), leukotriene E 4 (LTE4), is associated with an increased pain rate in children and adults with sickle cell disease (SCD). To provide additional evidence for a role of CysLTs in the pathogenesis of vaso-occlusion, we tested the hypothesis that LTE4 levels will increase within an individual during painful episodes compared to baseline. In a cohort of 19 children and adults with SCD, median LTE4 levels increased from 82.36 pg/mg creatinine at baseline to 162.81 pg/mg creatinine during a painful episode (P < 0.001). These data further support a contribution of CysLTs to the process of vaso-occlusion. © 2009 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Field, J. J., Strunk, R. C., Knight-Perry, J. E., Blinder, M. A., Townsend, R. R., & DeBaun, M. R. (2009). Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. American Journal of Hematology, 84(4), 231–233. https://doi.org/10.1002/ajh.21370

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free